Let’s start up with the current stock price of Cocrystal Pharma Inc. (COCP), which is $1.70 to be very precise. The Stock rose vividly during the last session to $1.64 after opening rate of $1.53 while the lowest price it went was recorded $1.48 before closing at $1.60.
Recently in News on May 14, 2020, Cocrystal Pharma Reports First Quarter 2020 Financial Results and Provides Updates on Antiviral Programs. – Company has sufficient capital to advance pipeline and fund operations through 2021 -. You can read further details here
Cocrystal Pharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.5000 on 02/25/20, with the lowest value was $0.4500 for the same time period, recorded on 01/13/20.
Cocrystal Pharma Inc. (COCP) full year performance was -24.04%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cocrystal Pharma Inc. shares are logging -42.37% during the 52-week period from high price, and 340.30% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.39 and $2.95.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5862793 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Cocrystal Pharma Inc. (COCP) recorded performance in the market was 222.91%, having the revenues showcasing 119.18% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 80.11M, as it employees total of 11 workers.
Market experts do have their say about Cocrystal Pharma Inc. (COCP)
During the last month, 0 analysts gave the Cocrystal Pharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.0295, with a change in the price was noted +1.1370. In a similar fashion, Cocrystal Pharma Inc. posted a movement of +207.48% for the period of last 100 days, recording 5,673,766 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for COCP is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Cocrystal Pharma Inc. (COCP)
Raw Stochastic average of Cocrystal Pharma Inc. in the period of last 50 days is set at 84.33%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 81.33%. In the last 20 days, the company’s Stochastic %K was 82.19% and its Stochastic %D was recorded 80.85%.
Bearing in mind the latest performance of Cocrystal Pharma Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 222.91%. Additionally, trading for the stock in the period of the last six months notably improved by 191.55%, alongside a downfall of -24.04% for the period of the last 12 months. The shares increased approximately by 7.38% in the 7-day charts and went down by 72.04% in the period of the last 30 days. Common stock shares were driven by 119.18% during last recorded quarter.